Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery

Annals of Thoracic Surgery

Volumn 93, Issue 2, 2012, Pages 559-564

  Ouzounian, Maral ^a   Buth, Karen J ^a   Valeeva, Liliya ^a   Morton, Craig C ^a   Hassan, Ansar ^b   Ali, Imtiaz S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b SAINT JOHN REGIONAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT;

ACUTE CORONARY SYNDROME; AGED; AORTA BALLOON; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC OUTPUT, LOW; COMORBIDITY; CORONARY ARTERY BYPASS; DIABETES MELLITUS; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; HYPERTENSION; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NOVA SCOTIA; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84856107083     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.10.058     Document Type: Article

References (30)

1. M.A. Pfeffer, E. Braunwald, L.A. Moye et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
2. G.R. Dagenais, J. Pogue, K. Fox, M.L. Simoons, S. Yusuf Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials Lancet 368 2006 581 588
3. H.L. Lazar Role of angiotensin-converting enzyme inhibitors in the coronary artery bypass patient Ann Thorac Surg 79 2005 1081 1089
4. U. Benedetto, G. Melina, F. Capuano et al. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery J Cardiovasc Med (Hagerstown) 9 2008 1098 1103
5. P. Arora, S. Rajagopalam, R. Ranjan et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery Clin J Am Soc Nephrol 3 2008 1266 1273
6. S. Durrleman, R. Simon Flexible regression models with cubic splines Stat Med 8 1989 551 561
7. M.J. Bradburn, T.G. Clark, S.B. Love, D.G. Altman Survival analysis part III: multivariate data analysischoosing a model and assessing its adequacy and fit Br J Cancer 89 2003 605 611
8. W.A. Ghali, H. Quan, R. Brant et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models JAMA 286 2001 1494 1497
9. The Use of Medicines in the United States: Review of 2010 2010 IMS Institute for Healthcare Informatics Parsippany, NJ
10. ACE Inhibitor Myocardial Infarction Collaborative Group Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials Circulation 97 1998 2202 2212
11. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788
12. J. Lopez-Sendon, K. Swedberg, J. McMurray et al. Expert consensus document on angiotensin-converting enzyme inhibitors in cardiovascular disease The Task Force on ACE-inhibitors of the European Society of Cardiology Eur Heart J 25 2004 1454 1470
13. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
14. T.J. Anderson, E. Elstein, H. Haber, F. Charbonneau Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study) J Am Coll Cardiol 35 2000 60 66
15. A.R. Brasier, A. Recinos III, M.S. Eledrisi Vascular inflammation and the renin-angiotensin system Arterioscler Thromb Vasc Biol 22 2002 1257 1266
16. V.J. Dzau Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis Hypertension 37 2001 1047 1052
17. L. Kjoller-Hansen, R. Steffensen, P. Grande The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES) J Am Coll Cardiol 35 2000 881 888
18. M. Oosterga, A.A. Voors, Y.M. Pinto et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study) QUinapril on Vascular Ace and Determinants of Ischemia Am J Cardiol 87 2001 542 546
19. J.L. Rouleau, W.J. Warnica, R. Baillot et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery Circulation 117 2008 24 31
20. D.W. Pigott, C. Nagle, K. Allman, S. Westaby, R.D. Evans Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements Br J Anaesth 83 1999 715 720
21. M.Y. Rady, T. Ryan The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery Chest 114 1998 487 494
22. C.M. Webb, R. Underwood, C. Anagnostopoulos et al. The effect of angiotensin-converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgerya randomised study Eur J Cardiothorac Surg 13 1998 42 48
23. V. Barodka, S. Silvestry, N. Zhao et al. Preoperative renin-angiotensin system inhibitors protect renal function in aging patients undergoing cardiac surgery J Surg Res 167 2011 e63 e69
24. U. Benedetto, S. Sciarretta, A. Roscitano et al. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting Ann Thorac Surg 86 2008 1160 1165
25. M. Argenziano, J.M. Chen, A.F. Choudhri et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent J Thorac Cardiovasc Surg 116 1998 973 980
26. T. Carrel, L. Englberger, P. Mohacsi, P. Neidhart, J. Schmidli Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance J Card Surg 15 2000 347 353
27. K.J. Tuman, R.J. McCarthy, C.J. O'Connor, W.E. Holm, A.D. Ivankovich Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass Anesth Analg 80 1995 473 479
28. A. Miceli, R. Capoun, C. Fino et al. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting J Am Coll Cardiol 54 2009 1778 1784
29. D.S. Bach Angiotensin-converting enzyme inhibitor therapy at the time of coronary artery bypass surgery: when a friend turns mean-spirited J Am Coll Cardiol 54 2009 1785 1786
30. J.J. Bax, A.F. Schinkel, E. Boersma et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis Circulation 110 2004 II18 II22